Agenda
View Meeting Video
Friday, January 20, 2023
CME/CNE-accredited Conference
7:30 AM - 3:45 PM EST
Virtually via AJI Media Livecast powered by Accelevents
Login to Virtual Conference - Visit Virtual Exhibit Hall
Welcome and Introductions
Edward A. Stadtmauer, MD | Activity Director
Robert H. Vonderheide, MD, DPhil | Director, Abramson Cancer Center
KEYNOTE: Transplant and Cellular Therapy: What can you do in 35 years?
David. L. Porter, MD | Activity Co-Director
PANEL DISCUSSION
MODERATORS: Edward A. Stadtmauer, MD & Stephen J. Schuster, MD | Activity Co-Directors
PANEL:
Catherine E. Lai, MD, MPH | Activity Co-Director
Alison W. Loren, MD, MSCE | Activity Co-Director
David. L. Porter, MD | Activity Co-Director
Jakub Svoboda, MD | Activity Co-Director
NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS
MODERATOR: Stephen J. Schuster, MD | Activity Co-Director
Novel Therapies in Follicular and Marginal Zone Lymphomas
Advances in CLL and Mantle Cell Lymphoma
Updates in Management of Hodgkin Lymphoma
Jakub Svoboda, MD | Activity Co-Director
Therapeutic Advances in T-Cell Lymphomas
Targeted Therapy of Aggressive B-Cell Lymphomas
Evolving Role of Immune Modulation Therapies Including CART and Bispecific Antibodies in Lymphoma Management
Panel Discussion
MODERATOR: Stephen J. Schuster, MD | Activity Co-Director
PANEL:
Stefan K. Barta MD, MS, MRCPCUK | Hematology Oncology
Jordan S. Carter, MD | Hematology Oncology
Elise A. Chong, MD | Hematology Oncology
Gamil S. Hanna, MD | Hematology Oncology
Mitchell E. Hughes, PharmD, BCOP | Oncology Pharmacy
Danielle Land, MSN, CRNP | Hematology Oncology
Daniel J. Landsburg, MD | Hematology Oncology
Sunita D. Nasta, MD, FACP | Hematology Oncology
John P. Plastaras, MD, PhD | Radiation Oncology
Jakub Svoboda, MD | Activity Co-Director
Break and Visit Exhibits
UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA
Moderator: Keith W. Pratz, MD | Activity Co-Director
Emerging Treatment Options for AML/MDS
Update in Hereditary Myeloid Disorders
Update in CML and Myeloproliferative Disease
Immunotherapies of Acute Leukemias
Panel Discussion
MODERATORS: Keith W. Pratz, MD & Catherine E. Lai, MD, MPH | Activity Co-Directors
PANEL:
Alison Carulli, PharmD | Oncology Pharmacy
Elizabeth O. Hexner, MD, MSTR | Hematology Oncology
Ximena Jordan-Bruno, MD | Hematology Oncology
Lindsay M. Lee, MSN, CRNP | Hematology Oncology
Selina M. Luger, MD | Hematology Oncology
Alexander E. Perl, MD | Hematology Oncology
John P. Plastaras, MD, PhD | Radiation Oncology
Sunil Saroha, MD | Hematology Oncology
Break and Visit Exhibits
UPDATE IN BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY
MODERATORS: David L. Porter, MD & Alison W. Loren, MD, MSCE | Activity Co-Directors
CAR T Cells for Solid Tumors
Improving Access to Allogenic Transplant By Assessing Frailty
New Approaches to Preventing and Treating GVHD
Panel Discussion
MODERATORS: David L. Porter, MD & Alison W. Loren, MD, MSCE | Activity Co-Directors
PANEL:
Noelle Frey, MD | Hematology Oncology
Craig Freyer, PharmD | Oncology Pharmacy
Nasheed M. Hossain, MD | Hematology Oncology
Shannon R. McCurdy, MD | Hematology Oncology
Linda Perry, PA-C | Hematology Oncology
John P. Plastaras, MD, PhD | Radiation Oncology
CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA
Moderator: Edward A. Stadtmauer, MD | Activity Director
Smoldering Myeloma and Myeloma Precursor States
Initial Therapy for Multiple Myeloma Including Transplant
Role of Immunotherapy for Myeloma
Experimental Therapies for Relapsed Myeloma
Panel Discussion
MODERATOR: Edward A. Stadtmauer, MD | Activity Director
PANEL:
Adam D. Cohen, MD | Hematology Oncology
Alfred L. Garfall, MD | Hematology Oncology
Oxana Megherea, PharmD | Oncology Pharmacy
John P. Plastaras, MD, PhD | Radiation Oncology
Leah Power, MSN, CRNP | Hematology Oncology
Sandra P. Susanibar-Adaniya, MD | Hematology Oncology
Dan T. Vogl, MD, MSCE | Hematology Oncology